{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:58:31Z","timestamp":1792112311504,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jaac.2013.11.009","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T12:46:22Z","timestamp":1386333982000},"page":"153-173","source":"Crossref","is-referenced-by-count":141,"title":["Alpha-2 Agonists for Attention-Deficit\/Hyperactivity Disorder in Youth: A Systematic Review and Meta-Analysis of Monotherapy and Add-On Trials to Stimulant Therapy"],"prefix":"10.1016","volume":"53","author":[{"given":"Tomoya","family":"Hirota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2013.11.009_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archgenpsychiatry.2011.1603","article-title":"Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication\u00a0Adolescent Supplement","volume":"69","author":"Kessler","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1469-7610.2011.02446.x","article-title":"Trends in psychopathology across the adolescent years: what changes when children become adolescents, and when adolescents become adults?","volume":"52","author":"Costello","year":"2011","journal-title":"J\u00a0Child Psychol Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib3","first-page":"1439","article-title":"Increasing prevalence of parent-reported attention-deficit\/hyperactivity disorder among children\u2014United States, 2003 and 2007","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaac.2013.11.009_bib4","first-page":"678","article-title":"Using meta-analysis to compare the efficacy of medications for attention-deficit\/hyperactivity disorder in youths","volume":"34","author":"Faraone","year":"2009","journal-title":"P T"},{"key":"10.1016\/j.jaac.2013.11.009_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4088\/JCP.08m04902pur","article-title":"A comparison of the efficacy of medications for adult attention-deficit\/hyperactivity disorder using\u00a0meta-analysis of effect sizes","volume":"6","author":"Faraone","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1542\/peds.2011-2654","article-title":"ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents","volume":"128","author":"Wolraich","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2013.11.009_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004703-200602000-00001","article-title":"Long-term stimulant medication treatment of attention-deficit\/hyperactivity disorder: results from a population-based study","volume":"27","author":"Barbaresi","year":"2006","journal-title":"J\u00a0Dev Behav Pediatr"},{"key":"10.1016\/j.jaac.2013.11.009_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1056-4993(18)30108-1","article-title":"The stimulants revisited","volume":"9","author":"Wilens","year":"2000","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2013.11.009_bib9","first-page":"994","article-title":"Effect of stimulants on height and weight: a review of the literature","volume":"47","author":"Faraone","year":"2008","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4088\/JCP.11r07064","article-title":"Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics","volume":"72","author":"Correll","year":"2011","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/CHI.0b013e318197748f","article-title":"Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls","volume":"48","author":"Daughton","year":"2009","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib12","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","article-title":"ADHD drugs and serious cardiovascular events in children and young adults","volume":"365","author":"Cooper","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2013.11.009_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaac.2011.11.008","article-title":"Stimulants and cardiovascular events in youth with attention-deficit\/hyperactivity disorder","volume":"51","author":"Olfson","year":"2012","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib14","doi-asserted-by":"crossref","first-page":"e4627","DOI":"10.1136\/bmj.e4627","article-title":"Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study","volume":"345","author":"Winterstein","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jaac.2013.11.009_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/chi.0b013e31815a56f1","article-title":"Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature","volume":"47","author":"Wilens","year":"2008","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/cap.2013.0028","article-title":"A\u00a0review of the rationale and clinical utilization of \u03b12-adrenoreceptor agonists for the treatment of attention-deficit\/hyperactivity and related disorders","volume":"23","author":"Sallee","year":"2013","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.jaac.2013.11.009_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00023210-200923000-00005","article-title":"Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction","volume":"23","author":"Arnsten","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jaac.2013.11.009_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pbb.2011.01.020","article-title":"Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit\/hyperactivity\u00a0disorder and related disorders","volume":"99","author":"Arnsten","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jaac.2013.11.009_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1527-3458.2007.00026.x","article-title":"Guanfacine and guanfacine extended release: treatment for ADHD and related disorders","volume":"13","author":"Posey","year":"2007","journal-title":"CNS Drug Rev"},{"issue":"Suppl 8","key":"10.1016\/j.jaac.2013.11.009_bib20","first-page":"7","article-title":"Fundamentals of attention-deficit\/hyperactivity disorder: circuits and pathways","volume":"67","author":"Arnsten","year":"2006","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.biopsych.2004.11.004","article-title":"Locomotor hyperactivity induced by\u00a0blockade of prefrontal cortical \u03b1-2-adrenoceptors in monkeys","volume":"57","author":"Ma","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2008.09.058","article-title":"Association between the \u03b1-2C-adrenergic receptor gene and attention deficit hyperactivity disorder in a Korean sample","volume":"446","author":"Cho","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jaac.2013.11.009_bib23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/00004583-199509000-00010","article-title":"Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience","volume":"34","author":"Chappell","year":"1995","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004583-199501000-00013","article-title":"An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder","volume":"34","author":"Hunt","year":"1995","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00004583-199303000-00016","article-title":"Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic\u00a0disorders","volume":"32","author":"Steingard","year":"1993","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/chi.0b013e31815d9af7","article-title":"Clonidine for attention-deficit\/hyperactivity disorder: I. Efficacy and tolerability outcomes","volume":"47","author":"Palumbo","year":"2008","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A\u00a0placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib28","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2006-3695","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of guanfacine extended release in\u00a0children and adolescents with attention-deficit\/hyperactivity disorder","volume":"121","author":"Biederman","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2013.11.009_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaac.2010.11.005","article-title":"Clonidine extended-release tablets for pediatric patients with attention-deficit\/hyperactivity disorder","volume":"50","author":"Jain","year":"2011","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaac.2013.11.009_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jaac.2013.11.009_bib32","first-page":"448","article-title":"Guanfacine extended-release tablets (Intuniv), a nonstimulant selective \u03b1(2A)-adrenergic receptor agonist for attention-deficit\/hyperactivity disorder","volume":"35","author":"Cruz","year":"2010","journal-title":"P\u00a0T"},{"key":"10.1016\/j.jaac.2013.11.009_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ebmh.5.4.122","article-title":"Clonidine and methylphenidate were effective for attention deficit hyperactivity disorder in children with comorbid tics","volume":"5","author":"Goldberg","year":"2002","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.jaac.2013.11.009_bib34","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2165\/11205940-000000000-00000","article-title":"Guanfacine extended-release: in attention deficit hyperactivity disorder","volume":"70","author":"Muir","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.jaac.2013.11.009_bib35","first-page":"CD007990","article-title":"Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders","author":"Pringsheim","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.jaac.2013.11.009_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/cap.2010.0135","article-title":"Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit\/hyperactivity disorder","volume":"22","author":"Sallee","year":"2012","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2013.11.009_bib37","first-page":"111","article-title":"Treatment effects of oral and transdermal clonidine in\u00a0relation to methylphenidate: an open pilot study in ADD-H","volume":"23","author":"Hunt","year":"1987","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.jaac.2013.11.009_bib38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/cap.2008.0080","article-title":"Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"19","author":"Sallee","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2013.11.009_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/cap.2008.0152","article-title":"Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"19","author":"Spencer","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2013.11.009_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1352\/0047-6765(2001)039<0259:DBPCTO>2.0.CO;2","article-title":"Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation","volume":"39","author":"Agarwal","year":"2001","journal-title":"Ment Retard"},{"key":"10.1016\/j.jaac.2013.11.009_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/DBP.0b013e3181739b9d","article-title":"Guanfacine in children with autism and\/or intellectual disabilities","volume":"29","author":"Handen","year":"2008","journal-title":"J\u00a0Dev Behav Pediatr"},{"key":"10.1016\/j.jaac.2013.11.009_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-7138(09)60065-0","article-title":"Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial","volume":"24","author":"Hunt","year":"1985","journal-title":"J\u00a0Am Acad Child Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.95.1.74","article-title":"The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine","volume":"95","author":"Singer","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2013.11.009_bib44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/1469-7610.00443","article-title":"The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD","volume":"40","author":"van der Meere","year":"1999","journal-title":"J\u00a0Child Psychol Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/000992280003900102","article-title":"A\u00a0pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder","volume":"39","author":"Connor","year":"2000","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jaac.2013.11.009_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/tropej\/fmn117","article-title":"Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD","volume":"55","author":"Nair","year":"2009","journal-title":"J\u00a0Trop Pediatr"},{"key":"10.1016\/j.jaac.2013.11.009_bib47","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.clinthera.2007.09.020","article-title":"Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years","volume":"29","author":"Kisicki","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaac.2013.11.009_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004714-200104000-00015","article-title":"Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit\/hyperactivity disorder","volume":"21","author":"Taylor","year":"2001","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jaac.2013.11.009_bib49","first-page":"755","article-title":"Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Connor","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jaac.2013.11.009_bib50","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.CHI.0000046908.27264.00","article-title":"A\u00a0randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children","volume":"42","author":"Hazell","year":"2003","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib51","doi-asserted-by":"crossref","first-page":"e1406","DOI":"10.1542\/peds.2010-1260","article-title":"Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD","volume":"127","author":"Kollins","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2013.11.009_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/cap.2010.0064","article-title":"Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit\/hyperactivity disorder","volume":"21","author":"Kollins","year":"2011","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2013.11.009_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/CHI.0b013e318191769e","article-title":"Guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder: a placebo-controlled trial","volume":"48","author":"Sallee","year":"2009","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics: a randomized controlled trial","volume":"58","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jaac.2013.11.009_bib55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaac.2011.10.012","article-title":"A\u00a0controlled trial of extended-release guanfacine and psychostimulants for attention-deficit\/hyperactivity disorder","volume":"51","author":"Wilens","year":"2012","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib56","first-page":"1013","article-title":"Selective deficit in no-go performance induced by blockade of prefrontal cortical alpha 2-adrenoceptors in monkeys","volume":"14","author":"Ma","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.jaac.2013.11.009_bib57","unstructured":"Schwartz S, Correll CU. Atomoxetine for children and adolescents with attention deficit-hyperactivity disorder: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. [in-press]."},{"key":"10.1016\/j.jaac.2013.11.009_bib58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00787-009-0054-3","article-title":"Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis","volume":"19","author":"Faraone","year":"2010","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.chi.0000190352.90946.0b","article-title":"Do children and adolescents with ADHD respond differently to atomoxetine?","volume":"45","author":"Wilens","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1753-2000-2-25","article-title":"Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy","volume":"2","author":"Kratochvil","year":"2008","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"10.1016\/j.jaac.2013.11.009_bib61","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends\u00a0in the office-based treatment of children, adolescents, and adults with antipsychotics","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib62","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11920-013-0382-3","article-title":"Pharmacoepidemiology of\u00a0second-generation antipsychotic use for ADHD: trends and\u00a0implications for clinicians","volume":"15","author":"Birnbaum","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.jaac.2013.11.009_bib63","doi-asserted-by":"crossref","first-page":"e1577","DOI":"10.1542\/peds.2010-1361","article-title":"Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management","volume":"129","author":"Scotto Rosato","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2013.11.009_bib64","doi-asserted-by":"crossref","first-page":"e1562","DOI":"10.1542\/peds.2010-1360","article-title":"Treatment of maladaptive aggression in youth: CERT guidelines I. Engagement, assessment, and management","volume":"129","author":"Knapp","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2013.11.009_bib65","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/DBP.0b013e3181e121bd","article-title":"A\u00a0review of attention-deficit\/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder","volume":"31","author":"Connor","year":"2010","journal-title":"J\u00a0Dev Behav Pediatr"},{"key":"10.1016\/j.jaac.2013.11.009_bib66","first-page":"R1572","article-title":"The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla","volume":"273","author":"Ernsberger","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jaac.2013.11.009_bib67","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00004583-199704000-00017","article-title":"Case study: adverse response to clonidine","volume":"36","author":"Cantwell","year":"1997","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2013.11.009_bib68","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.2010-0165","article-title":"Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007","volume":"127","author":"Larson","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2013.11.009_bib69","first-page":"MR000033","article-title":"Industry sponsorship and research outcome","volume":"12","author":"Lundh","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaac.2013.11.009_bib70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/cap.2011.0024","article-title":"Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study","volume":"21","author":"Correll","year":"2011","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2013.11.009_bib71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11920-013-0382-3","article-title":"Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications","volume":"15","author":"Birnbaum","year":"2013","journal-title":"Curr Psychiatry Rep"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856713008186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856713008186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T23:17:22Z","timestamp":1647645442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856713008186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0890856713008186"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2013.11.009","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}